10-K Filing

STREAMEX CORP. CIK: 1530766 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001185185-22-000369`
Period End Date	20211231
Filing Date	20220331
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	biosig20211231_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 40 Cash Flow Statement 66 Stockholders Equity 50

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$11.66M	USD	Point-in-time
Cash	`Cash`	$28.27M	USD	Point-in-time
Inventory	`InventoryNet`	$768.00K	USD	Point-in-time
Inventory	`InventoryNet`	$1.88M	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$354.00K	USD	Point-in-time
Prepaid expenses and vendor deposits	`PrepaidExpenseCurrent`	$301.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.89M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$289.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$652.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$306.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$604.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$346.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$326.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$317.00K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$86.00K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$5.00K	USD	Point-in-time
Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	105.00	shares	Point-in-time
Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	105.00	shares	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	-	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$42.00K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$102.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	105.00	shares	Point-in-time
Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	105.00	shares	Point-in-time
Preferred Stock, liquidation preference (in Dollars)	`TemporaryEquityLiquidationPreference`	$105.00K	USD	Point-in-time
Total assets	`Assets`	$15.52M	USD	Point-in-time
Preferred Stock, liquidation preference (in Dollars)	`TemporaryEquityLiquidationPreference`	$105.00K	USD	Point-in-time
Total assets	`Assets`	$30.39M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $317 and $40 to related parties as of December 31, 2020 and 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.18M	USD	Point-in-time
Accounts payable and accrued expenses, including $317 and $40 to related parties as of December 31, 2020 and 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.72M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	$32.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	-	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$82.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.76M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.57M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$73.00K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$283.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.57M	shares	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$313.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.58M	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	-	USD	Point-in-time
Deferred revenue, long term	`DeferredRevenueNoncurrent`	$5.00K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$1.00K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$373.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$378.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.95M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.11M	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 30,764,792 and 23,323,087 issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$36.00K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 30,764,792 and 23,323,087 issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$31.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$181.34M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$201.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-188.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-157.00M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$12.24M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$24.37M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$802.00K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$515.00K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$219.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$15.52M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$30.39M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	$441.00K	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	-	USD	Annual
Cost of goods sold	`CostOfGoodsAndServicesSold`	$199.00K	USD	Annual
Gross profit	`GrossProfit`	$242.00K	USD	Annual
Gross profit	`GrossProfit`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$18.14M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.60M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$40.95M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$27.85M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$198.00K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$94.00K	USD	Annual
Total operating expenses	`OperatingExpenses`	$59.18M	USD	Annual
Total operating expenses	`OperatingExpenses`	$33.65M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-33.41M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-59.18M	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$2.00K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$45.00K	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	$553.00K	USD	Annual
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Loss on foreign currency translation	`GainLossOnDispositionOfAssets1`	$-1.00K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-32.86M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-59.14M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-32.86M	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-939.00K	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.92M	USD	Annual
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-52.22M	USD	Annual
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-31.92M	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$14.00K	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$9.00K	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.93M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-52.23M	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-0.95	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-1.87	USD	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	27.91M	shares	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	33.51M	shares	Annual

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-32.86M	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$198.00K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$94.00K	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$441.00K	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$456.00K	USD	Annual
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$9.50M	USD	Annual
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$25.16M	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	$553.00K	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Change in fair value of modified options	`EquityFairValueAdjustment`	-	USD	Annual
Change in fair value of modified options	`EquityFairValueAdjustment`	$-321.00K	USD	Annual
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	Annual
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	-	USD	Annual
Fair value of subsidiary stock issued to acquire research and development	`ShareBasedCompensation`	$1.30M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$287.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$1.11M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$119.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$50.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$38.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$-18.00K	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$60.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.99M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.23M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-458.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-396.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.40M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$26.40M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.60M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$542.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$87.00K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-542.00K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-87.00K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.05M	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.00M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$16.16M	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.21M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.00M	USD	1 Quarter
Proceeds from sale subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromMinorityShareholders`	-	USD	Annual
Proceeds from sale subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromMinorityShareholders`	$10.59M	USD	Annual
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$1.30M	USD	Annual
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$2.23M	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$2.72M	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$28.00K	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.09M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.33M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.85M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-16.61M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$16.16M	USD	Annual
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.27M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.66M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.11M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.27M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.66M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.11M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$14.00K	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.00K	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$800.00K	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$2.00K	USD	Annual

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Sale of common stock, transactional costs (in Dollars)	`PaymentsOfStockIssuanceCosts`	$995.00K	USD	Annual
Sale of common stock, transactional costs (in Dollars)	`PaymentsOfStockIssuanceCosts`	$222.40K	USD	1 Quarter
Sale of common stock, transactional costs (in Dollars)	`PaymentsOfStockIssuanceCosts`	$40.37K	USD	Point-in-time
Sale of common stock, transactional costs (in Dollars)	`PaymentsOfStockIssuanceCosts`	$93.42K	USD	Point-in-time
Preferred Stock, per share	`PreferredStockRedemptionPricePerShare`	$50.00	USD	Point-in-time
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$2.96	USD	Annual
Options, per share	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$5.08	USD	Annual
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$2.27	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.16	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$10.00	USD	Point-in-time
Warrants, per share	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$3.75	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	35.57M	shares	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.23M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$10.59M	USD	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$25.21M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.30M	USD	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	251,720.00	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.19M	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.07M	shares	Point-in-time
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	83,055.00	shares	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.50M	shares	Point-in-time
Change in fair value of modified options	`OtherNoncashExpense`	$321.00K	USD	Annual
Sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$9.00M	USD	Annual
Sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$10.59M	USD	Annual
Sale of subsidiary shares to non-controlling interest (in Shares)	`StockIssuedDuringPeriodSharesOther`	206,250.00	shares	Point-in-time
Sale of subsidiary shares to non-controlling interest (in Shares)	`StockIssuedDuringPeriodSharesOther`	83,055.00	shares	Annual
Sale of subsidiary shares to non-controlling interest (in Shares)	`StockIssuedDuringPeriodSharesOther`	83,055.00	shares	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.66M	USD	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$4.40M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$3.98M	USD	Annual
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	658,868.00	shares	Point-in-time
Fair value of subsidiary shares issued to acquire research and development	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$1.30M	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.77M	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.53M	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$14.00K	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$9.00K	USD	Annual
Net loss	`ProfitLoss`	$-59.14M	USD	Annual
Net loss	`ProfitLoss`	$-32.86M	USD	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.20M	shares	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	550,000.00	shares	Point-in-time
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	9,375.00	shares	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.17M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	30.76M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	35.57M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.